Back to GetFilings.com



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 


 

FORM 10-Q

(Mark One)

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended March 31, 2004

 

 

OR

 

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                 to                

 

Commission File Number: 333-76055

 


 

UNITED INDUSTRIES CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

43-1025604

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

2150 Schuetz Road
St. Louis, Missouri 63146

(Address of principal executive office, including zip code)

 

 

 

(314) 427-0780

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý  No o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes o   No ý

 

As of May 14, 2004, the registrant had 30,121,162 Class A voting and 30,121,162 Class B nonvoting shares of common stock outstanding.

 

 



 

UNITED INDUSTRIES CORPORATION

QUARTERLY REPORT ON FORM 10-Q

FOR THE PERIOD ENDED MARCH 31, 2004

 

TABLE OF CONTENTS

 

 

Page

 

 

PART I. FINANCIAL INFORMATION

4

 

 

Item 1. Financial Statements (Unaudited)

4

 

 

 

Consolidated Balance Sheets as of March 31, 2004 and 2003 and December 31, 2003

4

 

 

 

 

Consolidated Statements of Operations and Comprehensive Income for the Three Months
Ended March 31, 2004 and 2003

5

 

 

 

 

Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2004 and 2003

6

 

 

 

 

Notes to Consolidated Financial Statements

7

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

27

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

42

 

 

Item 4. Controls and Procedures

44

 

 

PART II. OTHER INFORMATION

45

 

 

Item 1. Legal Proceedings

45

 

 

Item 6. Exhibits and Reports on Form 8-K

45

 

 

SIGNATURES

46

 

 

EXHIBIT INDEX

47

 

2



 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report contains forward-looking statements. These statements are subject to a number of risks and uncertainties, many of which are beyond our control. All statements other than statements of historical facts included in this Quarterly Report, including statements regarding our strategy, future operations or financial position, estimated revenues, projected costs, projections, plans and objectives of management, are forward-looking statements. As may be used in this Quarterly Report, the words “will,” “should,” “believe,” “plan,” “may,” “strategies,” “goals,” “anticipate,” “indicate,” “intend,” “determine,” “estimate,” “expect,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. All forward-looking statements apply only as of the date they are disclosed and are based on our expectations at that time. We do not undertake any obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Although we believe that our plans, intentions and expectations reflected in or suggested by any forward-looking statements we make in this Quarterly Report are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved.

 

Our actual results could differ significantly from the results discussed in any forward-looking statements contained in this Quarterly Report.  Factors that could cause or contribute to such differences include, without limitation, the following:

 

                                          general economic and business conditions;

 

                                          the loss or bankruptcy of major customers, suppliers or parties with whom we have a strategic relationship;

 

                                          the loss of a significant amount of products purchased by major customers;

 

                                          weather conditions and/or historical seasonality;

 

                                          our ability to repay our indebtedness or meet other obligations;

 

                                          industry trends and competition;

 

                                          our ability to manage rapid growth and the integration of acquisitions;

 

                                          our ability to achieve the benefits we expect from acquisitions, including the Nu-Gro Corporation transaction;

 

                                          our ability to successfully implement our enterprise resource planning, or ERP, system;

 

                                          public perception regarding the safety of our products;

 

                                          governmental regulations;

 

                                          terrorist attacks or acts of war;

 

                                          cost and availability of raw materials;

 

                                          changes in our business strategy or development plans;

 

                                          our ability to recruit and retain quality personnel;

 

                                          availability, terms and deployment of capital resources; and

 

                                          the other risks described in our filings with the SEC, including our Annual Report on Form 10-K.

 

TRADEMARKS

 

Spectracide®, Spectracide Triazicide®, Spectracide Terminate®, Spectracide Pro®, Hot Shot®, Garden Safe®, Schultz™, Rid-a-Bug®, Bag-a-Bug®, Real-Kill®, No-Pest®, Repel®, Vigoro®, Sta-Green®, Bandini®, CILÒ, WilsonÒ, PickseedÒ, So-GreenÒ, Plant-ProdÒ, GreenleafÒ, Green EarthÒ, IB NitrogenÒ, NitroformÒ,NutraleneÒ, OrganiformÒ and SCUÒ are our trademarks and trade names. We also license certain Cutter® trademarks from Bayer A.G. and certain Peters® and Peters Professional® trademarks from The Scotts Company. Other trademarks and trade names used in this Quarterly Report are the property of their respective owners.

 

3



 

PART I.  FINANCIAL INFORMATION

 

ITEM 1.  FINANCIAL STATEMENTS
 

UNITED INDUSTRIES CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except share data)

(Unaudited)

 

 

 

March 31,

 

December 31,

 

 

 

2004

 

2003

 

2003

 

 

 

(As Restated)

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

 

$

 

$

11,413

 

Accounts receivable, less reserves of $4,371 and $4,950
at March 31, 2004 and 2003, respectively, and $2,753 at December 31, 2003

 

146,730

 

139,537

 

29,890

 

Inventories

 

115,318

 

98,119

 

96,795

 

Prepaid expenses and other current assets

 

17,997

 

10,524

 

15,141

 

Total current assets

 

280,045

 

248,180

 

153,239

 

 

 

 

 

 

 

 

 

Equipment and leasehold improvements, net

 

41,510

 

33,649

 

37,153

 

Deferred tax asset

 

178,970

 

96,739

 

186,562

 

Goodwill

 

6,221

 

8,868

 

6,221

 

Intangible assets, net

 

86,037

 

87,670

 

86,872

 

Other assets, net

 

8,997

 

15,163

 

9,897

 

Total assets

 

$

601,780

 

$

490,269

 

$

479,944

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Current maturities of long-term debt and capital lease obligations

 

$

3,796

 

$

1,590

 

$

1,349

 

Accounts payable

 

60,685

 

59,016

 

29,774

 

Accrued expenses

 

58,729

 

66,313

 

39,574

 

Short-term borrowings

 

61,525

 

10,100

 

 

Total current liabilities

 

184,735

 

137,019

 

70,697

 

 

 

 

 

 

 

 

 

Long-term debt, net of current maturities

 

387,219

 

431,328

 

387,657

 

Capital lease obligations, net of current maturities

 

3,231

 

3,577

 

3,191

 

Other liabilities

 

3,222

 

4,048

 

3,256

 

Total liabilities

 

578,407

 

575,972

 

464,801

 

 

 

 

 

 

 

 

 

Commitments and contingencies (see Notes 10 and 11)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity (deficit):

 

 

 

 

 

 

 

Preferred stock (37,600 shares of $0.01 par value Class A issued
and outstanding, 40,000 shares authorized)

 

 

 

 

Common stock (33.2 million shares each of $0.01 par value Class A and
Class B issued, 30.1 million shares of each outstanding and 43.6 million shares of each authorized at March 31, 2004; 33.2 million shares each of $0.01 par value Class A and Class B issued and outstanding, 43.6 million shares of each authorized at March 31, 2003 and December 31, 2003

 

665

 

664

 

665

 

Treasury stock (3.1 million shares each of $0.01 par value Class A and
Class B, at cost at March 31, 2004; no shares at March 31, 2003; 9,569 shares each of $0.01 par value

 

 

 

 

 

 

 

Class A and Class B, at cost at December 31, 2003)

 

(24,469

)